Dog Chemotherapy Success Rate: What to Expect

There's no single success rate for chemotherapy in dogs, because it depends on the type of cancer and on what "success" means. In veterinary oncology, the usual goal isn't a cure. It's more time with a good quality of life (Penn Vet Ryan Hospital, 2017).

Measured that way, chemotherapy works well for some cancers. More than 90% of dogs with lymphoma respond at first to multidrug chemotherapy, with median survival of about 12 months for B-cell lymphoma and 6 to 8 months for T-cell lymphoma, compared with 4 to 6 weeks without treatment (Fan, 2023). For other cancers, chemotherapy is added to surgery to slow spread. Dogs with osteosarcoma treated with amputation plus carboplatin had a median survival of 321 days, significantly longer than reported for amputation alone (Bergman et al., 1996).

Most dogs tolerate chemotherapy better than people do. Pets generally have fewer side effects, and most side effects are mild and can be managed at home (Penn Vet Ryan Hospital, 2017).

Key points

• The goal of chemotherapy in dogs is usually to extend life while preserving quality of life, not to cure (Penn Vet Ryan Hospital, 2017).
• More than 90% of dogs with lymphoma respond at first to multidrug chemotherapy, though relapse is expected in most (Fan, 2023).
• Most dogs with lymphoma reach complete remission, lasting a median of 7 to 10 months, with median survival of 10 to 14 months (Zandvliet, 2016).
• For splenic hemangiosarcoma, adding chemotherapy to surgery raised average survival from about 2 months to about 4 to 6 months (Cornell University College of Veterinary Medicine [Cornell], 2024b).
• In an owner survey, 57% of pets had some side effects, most often tiredness and reduced appetite, and 89% of owners didn't regret treating (Bowles et al., 2010).
• Serious side effects are uncommon, and gastrointestinal effects usually appear 3 to 5 days after a treatment (Penn Vet Ryan Hospital, 2017).

Detailed explanation

What "success" means in veterinary chemotherapy

When people hear "chemotherapy," they often think of the intensive treatment used to try to cure human cancers. Veterinary chemotherapy is designed differently. In many cases, a cure is unrealistic, and the goal is to prolong survival while preserving quality of life (Penn Vet Ryan Hospital, 2017). That's why success is usually measured in a few ways:

• Response rate: the share of dogs whose cancer shrinks
• Remission: a period when the cancer can't be detected
• Survival time: how long dogs live, usually reported as a median
• Quality of life: how well dogs feel during treatment

A median survival time is the point at which half of the dogs in a study were still alive. Some dogs live much longer and some shorter. Our article on how much additional time treatment can give explains these numbers further.

Lymphoma: where chemotherapy works best

Lymphoma is one of the cancers where chemotherapy has the clearest benefit in dogs. With multidrug protocols, initial response rates are 90% or higher (Fan, 2023). Most dogs achieve complete remission, which lasts a median of 7 to 10 months, and median survival is 10 to 14 months (Zandvliet, 2016). Without treatment, most dogs die or are euthanized within 4 to 6 weeks (Fan, 2023).

The type of lymphoma matters. Median survival is about 12 months for B-cell lymphoma and about 6 to 8 months for T-cell lymphoma (Fan, 2023). Relapse is expected in most dogs eventually, largely because lymphoma cells become resistant to the drugs over time (Fan, 2023; Zandvliet, 2016). Many studies have looked for factors that predict how well a dog will do. In a 2023 review, immunophenotype (B-cell or T-cell) was one of the factors most consistently linked to outcome (Bennett et al., 2023).

Our guides to the CHOP protocol, lymphoma chemotherapy, and the lymphoma remission timeline go into detail. If you're still in the diagnosis stage, see canine lymphosarcoma symptoms.

Osteosarcoma: chemotherapy to slow spread

Osteosarcoma, a bone cancer, has often already spread to the lungs microscopically by the time it's diagnosed (Cornell, 2024a). Surgery removes the bone tumor, and chemotherapy is used to slow the spread that can't be seen.

In a prospective trial of 48 dogs treated with amputation and carboplatin, median disease-free interval was 257 days, median survival was 321 days, and 35.4% of dogs were alive at one year. Survival was significantly longer than previously reported for amputation alone (Bergman et al., 1996). Our article on osteosarcoma prognosis covers newer data and other treatment options.

Hemangiosarcoma: modest gains

Hemangiosarcoma of the spleen has no cure (Cornell, 2024b). Surgery alone is considered palliative, with average survival of about two months. Adding chemotherapy raises median survival to about four to six months, though fewer than 10% of dogs are alive a year after diagnosis (Cornell, 2024b). For many families, those extra months matter. Our article on hemangiosarcoma life expectancy explains the options.

Other cancers

Chemotherapy is used for many other cancers, and its benefit varies widely. For some, the evidence is strong; for others, it's limited or mixed. Ask your oncologist what the evidence shows for your dog's specific cancer, and what outcome they'd consider a success. Our overview of chemotherapy for dogs explains how drugs are chosen.

Side effects and quality of life

Compared with people, pets experience fewer side effects of chemotherapy. Most side effects are mild and either resolve on their own or can be relieved with medications given at home. Severe side effects are uncommon, though possible (Penn Vet Ryan Hospital, 2017). Stomach and intestinal effects usually show up 3 to 5 days after a treatment. Dogs with non-shedding coats, such as Poodles and some terriers, may lose some hair, especially on the face and tail, and it regrows after treatment ends, sometimes a different color or texture (Penn Vet Ryan Hospital, 2017).

Owners' experiences support this. In a survey of owners whose pets received carboplatin, 57% of pets had some side effects, most often tiredness and reduced appetite, with vomiting and diarrhea less common. Owners rated their pet's quality of life at its best during treatment as significantly higher than right after diagnosis, and 89% didn't regret treating. Support for pet chemotherapy among these owners rose from 32% before treatment to 89% after (Bowles et al., 2010). That was a small study of 28 pets, but it reflects what many oncology teams see.

Our chemotherapy side effects timeline walks you through what to watch for after each treatment.

Is chemotherapy worth it for your dog?

That depends on the cancer, your dog's overall health, what you want from treatment, and practical factors such as cost and travel. Chemotherapy may make sense if it's likely to give your dog meaningful extra time with a good quality of life. It may not if the expected benefit is small, your dog has other serious health problems, or treatment would be very stressful. Choosing not to treat is also a valid decision. Our articles on the cost of treating cancer in dogs and on choosing no treatment can help you weigh it.

When to contact a veterinarian

If your dog is receiving chemotherapy, call your veterinary team the same day if your dog:

• Has a fever, or seems lethargic or unwell
• Vomits more than once or twice, or has diarrhea lasting more than a day
• Won't eat for more than a day
• Has unusual bruising or bleeding

Go to an emergency hospital right away if your dog collapses, has trouble breathing, or has bloody diarrhea with weakness.

Questions to ask your veterinarian

• What's the realistic goal of chemotherapy for my dog's cancer: remission, more time, or comfort?
• What response rate and survival time have studies shown for this cancer and protocol?
• What happens if we don't treat?
• What side effects are most likely, and how will we manage them at home?
• How will we know whether the treatment is working?
• What's the total expected cost and time commitment?
• If the cancer comes back, what are the options?

References

Bennett, P., Williamson, P., & Taylor, R. (2023). Review of canine lymphoma treated with chemotherapy: Outcomes and prognostic factors. Veterinary Sciences, 10(5), Article 342. 

Bergman, P. J., MacEwen, E. G., Kurzman, I. D., Henry, C. J., Hammer, A. S., Knapp, D. W., Hale, A., Kruth, S. A., Klein, M. K., Klausner, J., Norris, A. M., McCaw, D., Straw, R. C., & Withrow, S. J. (1996). Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993). Journal of Veterinary Internal Medicine, 10(2), 76-81. 

Bowles, D. B., Robson, M. C., Galloway, P. E., & Walker, L. (2010). Owners' perception of carboplatin in conjunction with other palliative treatments for cancer therapy. Journal of Small Animal Practice, 51(2), 104-112. 

Cornell University College of Veterinary Medicine. (2024a). Osteosarcoma in dogs. Richard P. Riney Canine Health Center. Retrieved November 10, 2026, from https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-information/osteosarcoma-dogs

Cornell University College of Veterinary Medicine. (2024b). Hemangiosarcoma in dogs. Richard P. Riney Canine Health Center. Retrieved November 10, 2026, from https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-information/hemangiosarcoma-dogs

Fan, T. M. (2023). Lymphoma in dogs. Merck Veterinary Manual, Professional Version. Retrieved November 10, 2026, from https://www.merckvetmanual.com/circulatory-system/canine-lymphoma/canine-lymphoma

Penn Vet Ryan Hospital. (2017). Chemotherapy in veterinary medicine [Client information sheet]. Comprehensive Cancer Care Service, University of Pennsylvania School of Veterinary Medicine. https://www.vet.upenn.edu/wp-content/uploads/2025/05/chemotherapy-in-veterinary-medicine.pdf